血吸虫病是由复殖寄生吸虫引起的以虫卵肉芽肿和肝纤维化为主要特征的免疫性疾病 ,呈全球性分布 ,在 74个国家大约 2亿人受到不同程度的感染 ,6亿人受到潜在的威胁[1]。血吸虫病的治疗已取得突破性进展 ,但是由于反复感染发生迅速 ,需要重复治疗 ,血吸虫病仍难以控制。故发展血 Schistosomiasis is an autoimmune disease characterized by ova granulomas and hepatic fibrosis caused by a parasitic, parasitic, parasitic worm that is globally distributed and infects approximately 200 million people in 74 countries to varying degrees and infects 600 million people Potential threats [1]. The treatment of schistosomiasis has made breakthrough progress, but due to repeated infections that occur rapidly and require repeated treatments, schistosomiasis is still difficult to control. Therefore, the development of blood